Loading...
OctoPlus wins drug development and manufacturing contract from Danish pharmaceutical company
07-Jul-2011
- Netherlands
Advertisement
OctoPlus N.V. announced that a process development and manufacturing contract has been signed with a pharmaceutical company headquartered in Denmark. The undisclosed contract value will make a material contribution to OctoPlus' annual revenues.
Under the contract terms, OctoPlus will perform process development and manufacturing of a microsphere-based formulation for our client.